| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $62.0M | -59.6% |
| R&D Expense | $252.0M | +39.7% |
| SG&A Expense | $48.5M | -22.6% |
| Operating Income | -$238.5M | -167.1% |
| Pre-tax Income | -$225.1M | -154.1% |
| Income Tax | $2.4M | -87.0% |
| Net Income | -$227.5M | -113.0% |
| EPS (Basic) | -$2.96 | -66.3% |
| EPS (Diluted) | -$2.96 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.3M | +174.7% |
| Short-term Investments | $126.6M | -52.1% |
| Accounts Receivable | $8.6M | -76.1% |
| Current Assets | $343.3M | -18.6% |
| Total Assets | $387.2M | -17.7% |
| Current Liabilities | $131.9M | +40.7% |
| Total Liabilities | $342.6M | +6.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$191.5M | -71.6% |
| Investing Cash Flow | $218.5M | +5668.5% |
| Financing Cash Flow | $94.1M | -31.6% |
| -66.3% |
| Stockholders' Equity |
| $44.6M |
| -70.2% |